Elevation of serum direct bilirubin (DBIL) within the physiological range, coupled with the presence of the UGT1A1*6 mutation in Chinese patients with schizophrenia, may serve as potential protective factors against AAPD-induced dyslipidemia. This evidence concerns the gene UGT1A1 and metabolic syndrome.